Mohamed Elmeliegy

18PUBLICATIONS
28CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nutritional epidemiologyPharmaceutical delivery technologiesRegenerative medicine (incl. stem cells)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 29, 2026
Elranatamab: Mechanism of Action, Clinical, and Translational Science.

|Mar 02, 2026
Summary of Research: Elranatamab Fixed Dosing-A Safe, Effective, and Convenient Dosing Approach.

Mohamed Elmeliegy, Pooneh Soltantabar, Jennifer Hibma

|Feb 13, 2026
Advancing Pharmacoequity Globally: Reflections from the ASCPT Development, Regulatory, and Outcomes Network.

Priya Jayachandran, Mayur K Ladumor, Georgios Vlasakakis

|Dec 17, 2025
Elranatamab Exposure-Safety Analysis in Relapsed or Refractory Multiple Myeloma.

Pooneh Soltantabar, Jennifer Hibma, Diane Wang

|Feb 25, 2025
Dose Optimization of Elranatamab to Mitigate the Risk of Cytokine Release Syndrome in Patients with Multiple Myeloma.

Mohamed Elmeliegy, Andrea Viqueira, Erik Vandendries

Pageof 3